MPM BioImpact is a private equity firm and venture capital firm. Based in Boston, Massachusetts, United States. The known portfolio counts 15 companies, including Adlai Nortye, ReCode Therapeutics, Crossbow Therapeutics, Protego Biopharma, Edgewise Therapeutics and Reunion Neuroscience.
Is MPM BioImpact a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Who to pitch at MPM BioImpact
MPM BioImpact portfolio companies (15)
- Adlai Nortye
- ReCode Therapeutics
- Crossbow Therapeutics
- Protego Biopharma
- Edgewise Therapeutics
- Reunion Neuroscience
- Umoja Biopharma
- Deka Biosciences
- AstronauTx
- DBV Technologies
- NextPoint Therapeutics
- Trevi Therapeutics
- Frontier Medicines
- Firefly Bio
- āshibio
Co-investors
Funds that share portfolio companies with MPM BioImpact.
Similar funds
Showing 20 of 100
About MPM BioImpact
The firm's listing covers sector Healthcare, and focus areas Biotech, Clinical Trials, Drug Discovery and Genetics; known deals cluster at Growth, Late-Stage and Series A.
Of the 17 people on file at MPM BioImpact, Luke Evnin (Co-Founder), John Peng (Managing Partner) and Christiana Bardon (Co-Managing Partner) are listed as the contacts to approach first.
Across the known portfolio, 20 co-investors appear alongside MPM BioImpact, including Droia Ventures, Octagon Capital Advisors and Superstring Capital.
Frequently asked questions
What is MPM BioImpact?
MPM BioImpact is a private equity firm and venture capital firm based in Boston, Massachusetts, United States, with a known portfolio of 15 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does MPM BioImpact invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Drug Discovery and Genetics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does MPM BioImpact invest at?
The known deals of MPM BioImpact include Growth, Late-Stage and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at MPM BioImpact?
3 of the 17 people on file at MPM BioImpact are listed as contacts for the firm. All 17 have their own profile page.
How do I contact MPM BioImpact?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 17 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal